Adeel Shahzad
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 6
-
- Cardiomyopathy and Myosin Studies 7
- Acute Myocardial Infarction Research 6
- Atrial Fibrillation Management and Outcomes 5
- Cardiovascular Function and Risk Factors 5
- Cardiovascular Effects of Exercise 5
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Cardiac Arrhythmias and Treatments 2
Adeel Shahzad
18 papers receiving 462 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Internal Medicine 187
- Cardiology and Cardiovascular Medicine 422
- Surgery 165
- Radiology, Nuclear Medicine and Imaging 34
- Emergency Medicine 13
Countries citing papers authored by Adeel Shahzad
This map shows the geographic impact of Adeel Shahzad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adeel Shahzad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adeel Shahzad more than expected).
Fields of papers citing papers by Adeel Shahzad
This network shows the impact of papers produced by Adeel Shahzad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adeel Shahzad. The network helps show where Adeel Shahzad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adeel Shahzad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 15 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 2 | |
| 5 | 2019 | 2 | |
| 6 | 2018 | 4 | |
| 7 | 2018 | 2 | |
| 8 | 2018 | 3 | |
| 9 | 2017 | 19 | |
| 10 | 2016 | 0 | |
| 11 | Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients? | 2015 | 10 |
| 12 | 2015 | 42 | |
| 13 | 2015 | 1 | |
| 14 | 2015 | 11 | |
| 15 | Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trialbreakdown → | 2014 | 336 |
| 16 | 2014 | 5 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 2 | |
| 19 | QoS-supported energy-efficient MAC (QEMAC) protocol based on IEEE 802.11e for Wireless Multimedia Sensor Networks | 2011 | 5 |
About Adeel Shahzad
Adeel Shahzad is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Health Information Management, having authored 19 papers that have together received 471 indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (7 papers), Acute Myocardial Infarction Research (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Atrial Fibrillation Management and Outcomes (5 papers), Cardiovascular Function and Risk Factors (5 papers), Cardiovascular Effects of Exercise (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Cardiac Arrhythmias and Treatments (2 papers). The work is most often cited by research in Internal Medicine (187 citations), Cardiology and Cardiovascular Medicine (422 citations) and Surgery (165 citations). Adeel Shahzad has collaborated with scholars based in United Kingdom, Denmark and Argentina. Frequent co-authors include Rod Stables, Robert Cooper, Claire Roome, Christine Mars, Ian Kemp, Keith Wilson, Shahzad Munir, Nick Palmer, John L. Morris and Babu Kunadian. Their work appears in journals such as Echo Research and Practice, Journal of the American College of Cardiology, EuroIntervention, International Journal of Cardiology and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.